Emory Healthcare

Atlanta, Georgia 30329

4 studies enrolling now · 35 studies all time

What they study most

Accidental Fall, Acute Kidney Injury, Advanced Cancer, Agitation,Psychomotor, Alzheimer Dementia, Atrial Fibrillation (Permanent), COPD, Carotid Artery Disease, Catamenial Epilepsy, Covid19, Cystic Fibrosis, Diabetes Mellitus, Type 1

Studies at this site

• A Gaucher Disease Gene Therapy Trial With FLT201 — Recruiting now
• Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management — Recruiting now
• Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury — Recruiting now
• Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow — Recruiting now
• Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) — Completed
• COVID Protection After Transplant-Immunosuppression Reduction — Completed
• Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD) — Stopped early
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications — Completed
• TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure — Completed
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Running, not enrolling
• A Phase 1/2 Study of FS118 in Patients With Advanced Malignancies — Stopped early
• PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100) — Completed
• Effectiveness of Open and Robotic Prostatectomy — Completed
• Evaluating the Cost Effectiveness of STEADI — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600) — Completed
• Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine) — Completed
• Nasal Decolonization of Dialysis Patients Noses — Running, not enrolling
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone) — Completed
• ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400) — Completed
• A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures — Completed
• Open-label Extension to Protocol 1042-0600 — Completed
• DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry — Status unconfirmed
• Junctional AV Ablation in CRT-D: JAVA-CRT — Completed
• POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE — Completed
• Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated — Completed
• Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema — Completed
• Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks — Completed
• Pilot Study of the Spiration IBV™ System — Completed
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa — Completed
• EASE Trial: Exhale Airway Stents for Emphysema — Status unconfirmed
• Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease — Completed